Articles On Polynovo (ASX:PNV)

PolyNovo (ASX: PNV) shares are on watch this morning after releasing an FY20 trading update. What is PolyNovo? PolyNovo is an Australian medical device company that designs, develops, and manufactures dermal regeneration solutions using its...

I continue to believe that the mid cap space is a great place to look for long term investment ideas. This is because I feel there are a number of mid cap shares that have the potential to grow into large caps in the future, potentially ge...

Australia is an amazingly innovative country – from the medical application of penicillin, the invention of WiFi, right through to the cochlear implant or bionic ear. Heck, Australia was even the birthing ground for what would become Googl...

The Polynovo Ltd (ASX: PNV) share price was a strong performer last week and closed the five days of trade 8.1% higher at $2.66 per share. At the time of writing on Monday, Polynovo shares had edged slightly lower to $2.64. Shares in the A...

If you’re interested in adding some growth shares to your portfolio, then I think the three named below could be great options. I believe all three are well-positioned to deliver above-average earnings growth over the next few years and co...

It’s fair to say that investors in Polynovo Ltd (ASX: PNV) and JB Hi-Fi Limited (ASX: JBH) shares enjoyed a bumper last 12 months. For the financial year ending 30 June 2020 (FY20), both Polynovo and JB Hi-Fi shares rocketed around 63.9% h...

ShareCafeBest & Worst Performers On The ASX In FY 2019-20 There was the usual end of month, quarter, half-year and financial year window – dressing, tax selling and no doubt actual long term buying on the ASX yesterday. The last session...

Over the past 12 months, the S&P/ASX 200 (INDEXASX: XJO) is down 11%. But some ASX shares have bucked the trend and recorded major gains. We take a look at the top 10 performers over the past year.  Afterpay Ltd (ASX: APT) The Afterpay...

The S&P/ASX 200 Index (INDEXASX: XJO) fell by 1.5% yesterday, dragged down by most of the market. However, there was a number of shares that were able to defy the index and rose significantly. I think this is a good indicator of things...

If you’re a growth investor on the lookout for some new additions in July, then you might want to consider the three ASX shares listed below. I believe all three have the potential to generate strong returns for investors in the future. He...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is following the lead of U.S. markets and tumbling notably lower. At the time of writing the benchmark index is down 1.35% to 5,824.3 points. Four shares that have not let that hol...

The A2 Milk Company Ltd (ASX: A2M) share price has had an impressive run in the last 5 years. Shares in the Kiwi dairy group have rocketed 2,710.8% over that time to $18.27 per share. That means $10,000 invested 5 years ago would be worth...

With interest rates at ultra-low levels and looking likely to remain that way for the foreseeable future, I continue to believe investors would be better off putting any excess funds into the share market. But where should you invest these...

At lunch on Thursday the S&P/ASX 200 Index (ASX: XJO) looks set to end its positive run with a sizeable decline. The benchmark index is down 1.8% to 5,858.9 points. Here’s what has been happening on the market today: Qantas announces $...

Buying and holding ASX 200 shares can be a powerful way to build wealth and retire early. If equities are to form a crucial part of your retirement plans, obviously selecting the right shares to buy today is extremely important. For exampl...

The PolyNovo Ltd (ASX: PNV) share price may have jumped 56% over the last 12 months, but one fund manager believes it can still go higher. Who is bullish on PolyNovo? According to a recent update by the DNR Capital Australian Emerging Comp...

Michael Gable is an expert guest commentator for the Finance News Network, presenting “Stock Watch” each week – covering stock tips and shares on the Australian market (ASX). This video is dated 22 June 2020.  Shares covered: S&P 500, (...

The S&P/ASX 200 Index (ASX: XJO) fell by 0.9% today to 5,937 points. Today’s economic news was supplied by the Australian Bureau of Statistics (ABS). The data organisation said that total employment decreased by 227,700 people to 12.15...

Xero Limited (ASX: XRO) shares have been performing strongly in recent years and it looks like the cloud-based accounting software company is one of the hottest ASX growth shares right now. Personally, I think the Aussie company has strong...

ASX 200 shares continue to bounce back strongly in June. However, we’ve seen a minor wobble this week as the S&P/ASX 200 Index (ASX: XJO) has fallen lower for 2 consecutive days, and is down almost 3% this morning. Despite this, things...

There are a couple of ASX 200 biotech shares that could be in the buy zone right now. The S&P/ASX 200 Index (ASX: XJO) is down -10.25% this year but many Aussie healthcare companies have surged in value. This is partly due to the natur...

Healthcare is not the favourite child it was at the start of the COVID-19 pandemic, but one index measuring the sector is still up on the wider market. Biotech Daily’s top 40 index is up 14 per cent over the last month, compared to 4 per ce...

The PolyNovo Ltd (ASX: PNV) share price has been one of the best performers on the S&P/ASX 200 Index (ASX: XJO) over the last 12 months. Since this time last year the medical device company’s shares have climbed a massive 120%. If we g...

On Wednesday the S&P/ASX 200 Index (ASX: XJO) fought hard but fell just short at the close. The benchmark index dropped 5 points to 5,775 points. Will the market be able to bounce back from this on Thursday? Here are five things to wat...

Around 12 months ago, we noted that Avita Medical (AVH) – which provides a novel approach to skin regeneration – was a business worth keeping tabs on.  Although its share price has felt the effects of the COVID-19 market sell-off, our posit...

Building a massive portfolio of ASX shares from scratch is no easy feat. Creating real wealth through the share market takes time, dedication and discipline. But it can be done, nonetheless. One thing I’ve learned over time is that sometim...

Many ASX growth shares have rocketed higher despite the bear market in 2020. The S&P/ASX 200 Index (ASX: XJO) has slumped 16.60% lower this year while many top tech and healthcare shares have surged. But with all the craziness in the s...

We’re almost 2 months on from the fastest bear market on record, which saw the S&P/ASX 200 Index (ASX: XJO) fall 36.53% from 7,162.50 points on 20 February to a low of just 4,546 on 23 March. In the time since, however, the market has...

When it comes to investing in the ASX, I always prefer to look well into the future. Markets like the S&P/ASX 200 Index (ASX: XJO) already operate based on many forward-looking mechanisms. But in order to outperform the market over the...

Polynovo Ltd (ASX: PNV) shares could be about to surge in 2020. The ASX 200 healthcare company boasts a market capitalisation of $1.71 billion at the moment, but I think it could grow to be the next CSL Limited (ASX: CSL). Why the Polynovo...

The last year has been tough. We’ve had bushfires, floods, and now coronavirus. At the time of writing, the S&P/ASX 200 Index (ASX: XJO) is down 14% from this time a year ago. But where there is disaster, there is also opportunity. We...

Due to the market crash this year, the S&P/ASX 200 Index (ASX: XJO) has recorded a 7.5% decline over the last three years. While this is disappointing, not all shares on the market are down over the period. In fact, some have generated...

Would you have invested in Amazon in the 90s, when it was a scrappy startup exploiting this new thing called the ‘world wide web’? Or would you invest once it had bedded down the book business and was getting into groceries? With hindsight...

ShareCafeOvernight: Wing And A Prayer World Overnight SPI Overnight (Jun) 5405.00 – 11.00 – 0.20% S&P ASX 200 5407.10 + 87.30 1.64% S&P500 2868.44 + 25.70 0.90% Nasdaq Comp 8809.12 + 98.41 1.13% DJIA 23883.09 + 133.33 0....

World Overnight SPI Overnight (Jun) 5405.00 – 11.00 – 0.20% S&P ASX 200 5407.10 + 87.30 1.64% S&P500 2868.44 + 25.70 0.90% Nasdaq Comp 8809.12 + 98.41 1.13% DJIA 23883.09 + 133.33 0.56% S&P500 VIX 33.61 – 2.36 – 6....

After an initial fall in line with the COVID-19 influence on the ASX 200 [XJO], the PolyNovo Ltd [ASX:PNV] share price shot up 66.27% from its low to close at $2.12, at the time of writing. PolyNovo is an Australian-based medical device com...

PolyNovo (ASX:PNV) has released the summary of results for the CP-002 Feasibility Study to assess the safety and effectiveness of NovoSorb Biodegradable Temporizing Matrix (BTM) in the treatment of severe skin burn injuries.

2020 was looking good for many companies but COVID-19 changed all that. Some have needed capital to keep going and one was sleep apnoea mouthguard maker Somnomed (ASX:SOM). In February, the company reported solid revenue and operating profi...

There is no doubt coronavirus has hit the ASX hard – the S&P/ASX 200 Index (ASX: XJO) is down 21% since the start of the year and 26% from its February high. Volatility has continued as the market has clawed its way back from its low...

Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week. Three broker buy ratings that have caught my eye are summarised below. Here’s why br...

World Overnight SPI Overnight (Jun) 5190.00 – 52.00 – 0.99% S&P ASX 200 5252.30 – 34.50 – 0.65% S&P500 2659.41 – 4.27 – 0.16% Nasdaq Comp 7887.26 – 25.98 – 0.33% DJIA 22653.86 – 26.13 – 0.12% S&P500 VIX 46.70 + 1.4...

The S&P/ASX 200 Index (ASX: XJO) was volatile again on Tuesday. Initially the ASX 200 went up as much as 2.5%. Then during the day it dropped by around 4.2% by mid-afternoon, to finish down by 0.6% compared to yesterday. Investor confi...

07 Apr 2020 - PolyNovo (ASX:PNV) report sales for the March 2020 quarter were 166 per cent greater than the March 2019 quarter ($1.69 million v. $4.49 million).

Australian medical device company PolyNovo (ASX: PNV) has posted record US sales for the March 2020 quarter, validating an earlier claim that the coronavirus pandemic would not have any material impact on its business. The company’s sales f...

The S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is pushing higher on Tuesday. In late morning trade the benchmark index is up 8% to 5,333.4 points. Four shares that are climbing more than most today are liste...

In proof that biotechs will deliver market returns even during a pandemic, two companies this morning have issued clinical trial results and watched their share prices rocket. Pot stock Zelira Therapeutics (ASX:ZLD) has received the full re...

The S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is storming higher on Tuesday. The benchmark index is currently up 2.5% to 5,419.9 points. Three healthcare shares that are vastly outperforming the benchmark i...

ASX shares are trading at deep discounts from previous highs thanks to the coronavirus pandemic. This gives investors the chance to swoop in on some bargains. So, let’s take a look at 5 ASX shares to buy across the technology and healthca...

Director buys can be a sign that those with the most insight into a company view its shares as undervalued. Here we take a look at 4 ASX healthcare shares with multiple recent director buys.  What is insider buying? Insider buying is the p...

Despite the S&P/ASX 200 Index (ASX: XJO) plummeting lower in 2020, shares in ASX 200 healthcare group Polynovo Ltd (ASX: PNV) are still up 102% in the last 12 months. That’s good news for existing shareholders, but is there still time...